Name: Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities (en Inglés)
SKU: 60327925
Price: 225510.00 CLP
Availability: InStock
Author: Chopra, Dimple Sethi ; Kaul, Ankur
ISBN: 9781799803072

portada Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities (en Inglés)

Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities (en Inglés)

Formato

Libro Físico

Editorial

Medical Information Science Reference

Autor

Chopra, Dimple Sethi ; Kaul, Ankur

Idioma

Inglés

N° páginas

284

Encuadernación

Tapa Dura

Dimensiones

25.4x17.8x2.1 cm

Peso

0.81 kg.

ISBN13

9781799803072

Categorías

Enfermedades infectocontagiosas
Microbiología médica y virología

Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities (en Inglés)

Chopra, Dimple Sethi ; Kaul, Ankur (Autor) · Medical Information Science Reference · Tapa Dura

Libro Nuevo Importado

Envío: 16 a 21 días háb.

$ 410.010$ 225.510

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 225.510

Llega entre el 13 Oct y el 20 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities (en Inglés)"

Recently, there has been an upsurge in microbial infections. Extensive and inappropriate usage of antimicrobial drugs in treating infections has led to the evolution of a resistant strain of microorganisms and irreversible immunosuppression in humans. Medical institutions and hospitals require solutions to combat these contagions in order to avoid future epidemics. Strategies to Overcome Superbug Invasions: Emerging Research and Opportunities highlights current research and potential strategies to prevent the emergence and re-emergence of drug-resistant pathogenic microbial strains. The content within this publication examines biosensing, global initiatives, nanomaterials, and alternative therapies. It is designed for microbiologists, biotechnologists, pharmacists, pharmacologists, virologists, formulation scientists, infectious disease specialists, government officials, policymakers, healthcare practitioners, doctors, nurses, hospital directors, researchers, surgeons, and academicians who are seeking research on innovative solutions for multi-drug-resistant infections.